14-Hydroxymorphinone, is likely a schedule II controlled substance similar to other drugs in this class, is an opioid morphine based analgesic agent for pain. 14-Hydroxymorphinone is very similar to oxymorphone with only one carbon-carbon double bond difference on the ring containing the carbonyl group. 14-Hydroxymorphinone is very similar to oxycodone with only one carbon-carbon double bond difference on the ring containing the carbonyl group and an oxymethyl group off the benzene ring. 14-Hydroxymorphinone is a synthetic intermediate to other opioid agents.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for 14-Hydroxymorphinone, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’ OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.